How many insider declarations does Aurobindo Pharma Limited have?

Aurobindo Pharma Limited has filed 168 insider declarations with SEBI (PIT + SAST).

Who is the top reporting insider at Aurobindo Pharma Limited?

The top reporting insider at Aurobindo Pharma Limited is RPR SONS ADVISORS PVT.LTD., P.SUNEELA RANI (Jointly holding), based on the count of public filings.

What is the net insider buy vs sell volume on Aurobindo Pharma Limited?

Across the available history, declared buys total 1.2M€ and disposals 10.7M€.

InsidersTradesSigma

← Companies ★ Sign in to follow

Aurobindo Pharma Limited: insider trades · India · SEBI (PIT + SAST)

SEBI:aurobindo-pharma-limitedIN·SEBI (PIT + SAST)Mcap 674.0Bn€

AMF ↗

Discover the full management transaction log of Aurobindo Pharma Limited, a publicly traded company based in India. Shares are quoted on IN IN, under the supervision of SEBI (PIT + SAST). Market capitalisation: €674bn. The latest transaction was filed on 30 March 2024 (Pledge). Among the most active insiders: RPR SONS ADVISORS PVT.LTD., P.SUNEELA RANI (Jointly holding). All data is free.

168

Insider Decl.

0

Thresholds

€1m

4 ops.

Buy Volume

€11m

65 ops.

Sell Volume

Financial data

FY ended March 2025 · cache

1500.50 €

Income statement

Revenue313.78 Bn€

Gross profit176.37 Bn€56% margin

Net income34.86 Bn€11.1% margin

Balance sheet & cash

Market cap674.02 Bn€

Total debt82.63 Bn€

Free Cash Flow14.05 Bn€

Last declaration on 30 March 2024

All Executives168 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations

About Aurobindo Pharma Limited

Aurobindo Pharma Limited is an Indian pharmaceutical company specializing in the manufacture of generic drugs and pharmaceutical products. It is listed on the Bombay Stock Exchange under the symbol XBOM.